288 results on '"Lim, Joseph K."'
Search Results
2. AGA Clinical Practice Update on the Role of Noninvasive Biomarkers in the Evaluation and Management of Nonalcoholic Fatty Liver Disease: Expert Review
3. Chronic Hepatitis B Virus: What an Internist Needs to Know: Serologic Diagnosis, Treatment Options, and Hepatitis B Virus Reactivation
4. AGA Clinical Practice Update on Diagnosis and Management of Acute Hepatic Porphyrias: Expert Review
5. The ALT upper reference interval debate: Blame it on the alcohol
6. Severe Acute Liver Injury After Hepatotoxic Medication Initiation in Real-World Data.
7. Identification of hepatic steatosis among persons with and without HIV using natural language processing.
8. Risk factors for hepatocellular carcinoma (HCC) in the northeast of the United States : results of a case–control study
9. AGA Clinical Practice Update on Diagnosis and Management of Immune Checkpoint Inhibitor Colitis and Hepatitis: Expert Review
10. Protease inhibitor-based direct-acting antivirals are associated with increased risk of aminotransferase elevations but not hepatic dysfunction or decompensation
11. Prevalence and characteristics of hepatitis delta virus infection in patients with hepatitis B in the United States: An analysis of the All-Payer Claims Database.
12. Budd-Chiari Syndrome: An Uncommon Cause of Chronic Liver Disease that Cannot Be Missed
13. Direct-Acting Antivirals Improve Overall Survival in Interventional Oncology Patients with Hepatitis C and Hepatocellular Carcinoma
14. Hepatitis C: How Good Are Real-Life Data and Do Generics Work
15. Pathophysiology of Hepatic Encephalopathy
16. AGA Clinical Practice Update on Surveillance for Hepatobiliary Cancers in Patients With Primary Sclerosing Cholangitis: Expert Review
17. Excess Weight Gain After Cure of Hepatitis C Infection with Direct-Acting Antivirals
18. Medication Non-adherence in a Prospective, Multi-center Cohort Treated with Hepatitis C Direct-Acting Antivirals
19. Patient-reported symptoms during and after direct-acting antiviral therapies for chronic hepatitis C: The PROP UP study
20. Healthcare resource utilization and costs by disease severity in an insured national sample of US patients with chronic hepatitis B
21. Status of Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection and Remaining Challenges
22. Safety and Effectiveness of Ledipasvir and Sofosbuvir, With or Without Ribavirin, in Treatment-Experienced Patients With Genotype 1 Hepatitis C Virus Infection and Cirrhosis
23. Risk of Acute Liver Injury After Statin Initiation by Human Immunodeficiency Virus and Chronic Hepatitis C Virus Infection Status
24. A Comparison Between Community and Academic Practices in the USA in the Management of Chronic Hepatitis B Patients Receiving Entecavir: Results of the ENUMERATE Study
25. Low real-world eligibility rates for nonalcoholic steatohepatitis patients for phase 3 clinical trial criteria application in a large academic health system
26. HIV- and HCV-specific markers and echocardiographic pulmonary artery systolic pressure among United States veterans
27. Brief Report: Accuracy of FIB-4 for Cirrhosis in People Living With HIV and Hepatocellular Carcinoma
28. Liver fibrosis and accelerated immune dysfunction (immunosenescence) among HIV-infected Russians with heavy alcohol consumption - an observational cross-sectional study
29. Impact of Direct Acting Antivirals on Survival in Patients with Chronic Hepatitis C and Hepatocellular Carcinoma
30. Hepatitis C in Black Individuals in the US: A Review.
31. Clinical and Histopathological Discoveries in Patients with Hepatic Injury and Cholangiopathy Who Have Died of COVID-19: Insights and Opportunities for Intervention.
32. Performance of an automated deep learning algorithm to identify hepatic steatosis within noncontrast computed tomography scans among people with and without HIV.
33. Screening, Diagnosis, and Staging of Non-Alcoholic Fatty Liver Disease (NAFLD): Application of Society Guidelines to Clinical Practice.
34. Practice Patterns in Hepatitis B Virus Screening Before Cancer Chemotherapy in a Major US Hospital Network
35. Hepatic Safety of Buprenorphine in HIV-Infected and Uninfected Patients With Opioid Use Disorder: The Role of HCV-Infection
36. Evidence-based interventions to enhance assessment, treatment, and adherence in the chronic Hepatitis C care continuum
37. Determinants of Liver Complications Among HIV/Hepatitis B Virus–Coinfected Patients
38. Comparison of the prevalence, severity, and risk factors for hepatic steatosis in HIV-infected and uninfected people
39. Percutaneous decannulation of venoarterial extracorporeal membrane oxygenation using the Manta vascular closure device: A systematic review and meta‐analysis.
40. Hepatitis B care cascade among people with HIV/HBV coinfection in the North American AIDS Cohort Collaboration on Research and Design, 2012–2016.
41. Exercise Does Not Independently Improve Histological Outcomes in Biopsy-Proven Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.
42. Reply to Marcellin et al
43. Simeprevir plus sofosbuvir, with or without ribavirin, to treat chronic infection with hepatitis C virus genotype 1 in non-responders to pegylated interferon and ribavirin and treatment-naive patients: the COSMOS randomised study
44. Histologic Changes in Liver Tissue From Patients With Chronic Hepatitis B and Minimal Increases in Levels of Alanine Aminotransferase: A Meta-analysis and Systematic Review
45. Relationship Between Alcohol Use Categories and Noninvasive Markers of Advanced Hepatic Fibrosis in HIV-Infected, Chronic Hepatitis C Virus–Infected, and Uninfected Patients
46. Antiretroviral Therapy Reduces the Rate of Hepatic Decompensation Among HIV- and Hepatitis C Virus–Coinfected Veterans
47. Effectiveness and safety of sofosbuvir plus ribavirin for the treatment of HCV genotype 2 infection: results of the real-world, clinical practice HCV-TARGET study
48. FIB‐4 stage of liver fibrosis predicts incident heart failure among HIV‐infected and uninfected patients
49. Risk of liver decompensation with cumulative use of mitochondrial toxic nucleoside analogues in HIV/hepatitis C virus coinfection
50. Introduction of Clinical Practice Update Committee Articles
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.